Xiel acquired by MIS Healthcare to expand UK & Ireland presence
Xiel, a Shepton Mallet-based specialist distributor in nuclear medicine, radiotherapy, and diagnostic radiology, has been acquired by MIS Healthcare, a London-based leader in medical imaging solutions. This strategic acquisition expands MIS Healthcare’s medical portfolio across the UK and Ireland, reinforcing its position as a premier provider of diagnostic imaging services and cutting-edge oncology and radiotherapy equipment.
Our Corporate and Private Equity team, led by Melanie Williams and Laura Spendiff, and supported by Chloe Walsh, Nicole Crumbie and Benjamin Liebenberg, advised the Xiel shareholders on the sale to MIS Healthcare. They were supported by other specialists across the firm including our Commercial, Real Estate and Employment teams.
This acquisition marks a significant step in advancing healthcare technology and innovation in the region, and we are pleased to have played a role in facilitating it.
Jack Knight, Managing Director of Xiel, said:
Thank you to the whole team at Capital Law for their support. They were professional, committed and responsive from start to finish, and we found their down to earth approach made the process easy for the shareholders. We thoroughly enjoyed working with Mel, Laura and the team.
Melanie Williams, Capital Law’s Corporate & Private Equity Partner, said:
It was a genuine pleasure to work with the shareholders of Xiel. Jack and the team have built a great business and can look forward to an exciting future with MIS Healthcare. We’re delighted the team trusted us to support them and we wish them all the best for the future.
